Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
Research Software Engineer for Translational Biomedical AI Build the science that shapes the future of human health. Application closing date: 15.09.2026 Join a place where ambitious science thrives
-
human health. Within this mission, the Health Data Science Centre (HDSC) at HT has been planned in partnership with Politecnico di Milano and is developing several lines of research, with the aim to help
-
created role, you will build the function from the ground up, working closely with researchers, institutional leadership, industry and investors to translate scientific discoveries into real-world impact
-
qualified candidates to join its Management Committee, the governing body responsible for the operational leadership of the Foundation. The Committee appoints Centre Directors through international selection
-
human health. Within this mission, the Casale Group in the Health Data Science Centre develops AI methods that transform population-scale human data into mechanistic models of disease. Our research
-
human health. Within this mission, the Casale Group in the Health Data Science Centre develops AI methods that transform population-scale human data into mechanistic models of disease. Our research
-
human health. Within this mission, the Casale Group in the Health Data Science Centre develops AI methods that transform population-scale human data into mechanistic models of disease. Our research
-
Postdoctoral Position A postdoctoral position is available to develop next-generation electronic devices based on microbially produced protein nanowires. These biologically derived conductive
-
are seeking a Statistical Geneticist to contribute to innovative population and medical genomics research by developing robust analytical strategies and collaborating with multidisciplinary teams with a
-
, the Giustacchini group aim to develop stem-cell-based models of paediatric leukaemia to understand how malignant haematopoiesis interacts with the immune system and to improve responses to CAR T-cell therapy. We